elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38817063-6A8A28DA-72C8-47AD-AAFF-8C16B4476AEB
Q38817063-6A8A28DA-72C8-47AD-AAFF-8C16B4476AEB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38817063-6A8A28DA-72C8-47AD-AAFF-8C16B4476AEB
Investigational α-synuclein aggregation inhibitors: hope for Parkinson's disease.
P2860
Q38817063-6A8A28DA-72C8-47AD-AAFF-8C16B4476AEB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38817063-6A8A28DA-72C8-47AD-AAFF-8C16B4476AEB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
33110dbc584e7f4e267cb9d8851ef2f8a78e13a3
P2860
Development of Passive Immunotherapies for Synucleinopathies.